Improvement of Pig Islet Function by In Vivo Pancreatic Tissue Remodeling: A “Human-Like” Pig Islet Structure with Streptozotocin Treatment
Open Access
- 1 November 2013
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 22 (11) , 2161-2173
Abstract
Pig islets demonstrate significantly lower insulin secretion after glucose stimulation than human islets (stimulation index of ~12 vs. 2 for glucose 1 and 15 mM, respectively) due to a major difference in β- and α-cell composition in islets (60% and 25% in humans and 90% and 8% in pigs, respectively). This leads to a lower rise in 3′,5′-cyclic adenosine monophosphate (cAMP) in pig β-cells. Since glucagon is the major hormonal effector of cAMP in β-cells, we modified pig islet structure in vivo to increase the proportion of α-cells per islet and to improve insulin secretion. Selected doses (0, 30, 50, 75, and 100 mg/kg) of streptozotocin (STZ) were intravenously injected in 32 young pigs to assess pancreatic (insulin and glucagon) hormone levels, islet remodeling (histomorphometry for α- and β-cell proportions), and insulin and glucagon secretion in isolated islets. Endocrine structure and hormonal content of pig islets were compared with those of human islets. The dose of STZ was significantly correlated with reductions in pancreatic insulin content ( p < 0.05, r2 = 0.77) and the proportion of β-cells ( p < 0.05, r2 = 0.88). A maximum of 50 mg/kg STZ was required for optimal structure remodeling, with an increased proportion of α-cells per islet (26% vs. 48% α-cells per islet for STZ 75 mg/kg; p < 0.05) without β-cell dysfunction. Three months after STZ treatment (30/50 mg/kg STZ), pig islets were isolated and compared with isolated control islets (0 mg/kg STZ). Isolated islets from STZ-treated (30/50 mg/kg) pigs had a higher proportion of α-cells than those from control animals (32.0% vs. 9.6%, respectively, p < 0.05). After in vitro stimulation, isolated islets from STZ-treated pigs demonstrated significantly higher glucagon content (65.4 vs. 21.0 ng/ml, p < 0.05) and insulin release (144 μU/ml) than nontreated islets (59 μU/ml, p < 0.05), respectively. Low-dose STZ (<50 mg/kg) can modify the structure of pig islets in vivo and improve insulin secretion after isolation.Keywords
This publication has 38 references indexed in Scilit:
- Functional Capacity of Human Islets After Long-Distance Shipment and EncapsulationPancreas, 2011
- Conversion of adult pancreatic α-cells to β-cells after extreme β-cell lossNature, 2010
- Native pancreatic α-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantationXenotransplantation, 2009
- Nutrient control of insulin secretion in perifused adult pig isletsDiabetes & Metabolism, 2007
- Distribution of Pancreatic Endocrine Cells Including IAPP-expressing Cells in Non-diabetic and Type 2 Diabetic CasesJournal of Histochemistry & Cytochemistry, 2007
- Nutrient Control of Insulin Secretion in Isolated Normal Human IsletsDiabetes, 2006
- Identification and characterization of small cells in the adult pancreas: potential progenitor cells?Cell and tissue research, 2002
- Glucagon improves insulin secretion from pig islets in vitroJournal of Endocrinology, 1995
- PARADOXICAL RELEASE OF INSULIN BY ADULT PIG ISLETS IN VITROTransplantation, 1993
- Glucagon Secretion by Dispersed Alpha Cell Enriched Islets from Streptozotocin Treated Hamsters in PerifusionHormone and Metabolic Research, 1984